+86-13031714605
info@millionpharm.com

  • Company
    • About us

    • Partners

    • Value

    • Careers

  • Product
    • Pharmaceutical API

    • Advanced Intermediate

  • R&D&Site
  • News&Events
  • Sustainability
  • Contact Us

PRODUCTS


Home > Products > Pharmaceutical API
  • NAD+
    NAD+
  • peptides list, mg in vials,
    peptides list, mg in vials,
  • 5-Bromo-2-(methoxymethyl)-1-methyl-6-(trifluoromethyl)-1H-benzimidazol-4-amine
    5-Bromo-2-(methoxymethyl)-1-methyl-6-(trifluoromethyl)-1H-benzimidazol-4-amine
  • 4-BROMO-5-(TRIFLUOROMETHYL)-2-NITROBENZENAMINE
    4-BROMO-5-(TRIFLUOROMETHYL)-2-NITROBENZENAMINE
  • Benzenamine, 4-bromo-N-methyl-2-nitro-5-(trifluoromethyl)-
    Benzenamine, 4-bromo-N-methyl-2-nitro-5-(trifluoromethyl)-
  • 4-Bromo-N*1*-methyl-5-trifluoromethyl-benzene-1,2-diamine
    4-Bromo-N*1*-methyl-5-trifluoromethyl-benzene-1,2-diamine
  • 3-Butyne-1,2-diol, 2-methyl-4-(trimethylsilyl)-
    3-Butyne-1,2-diol, 2-methyl-4-(trimethylsilyl)-
  • Methanone, (8-bromo-3-indolizinyl)(3,4,5-trifluorophenyl)-
    Methanone, (8-bromo-3-indolizinyl)(3,4,5-trifluorophenyl)-
  • (8-Bromoindolizin-3-yl)(3,5-difluoro-4-((4-methoxybenzyl)amino)phenyl)methanone
    (8-Bromoindolizin-3-yl)(3,5-difluoro-4-((4-methoxybenzyl)amino)phenyl)methanone
  • (8-Bromoindolizin-3-yl)(4-((2,4-dimethoxybenzyl)amino)-3,5-difluorophenyl)methanone
    (8-Bromoindolizin-3-yl)(4-((2,4-dimethoxybenzyl)amino)-3,5-difluorophenyl)methanone
  • Methanone, [8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-indolizinyl](3,4,5-trifluorophenyl)-
    Methanone, [8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-indolizinyl](3,4,5-trifluorophenyl)-
  • Apixabn
    Apixabn
  • BPC 157
    BPC 157
  • Copper tripetide
    Copper tripetide
  • Mazidutide
    Mazidutide
  • Semagluti
    Semagluti
  • <Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next>
  • 

    Cerebro-cardiovascular

  • 

    Central nervous system

  • 

    Cancer/tumor

  • 

    Anti-diabetics

  • 

    R&D&Pipeline

  • 

    Other APIS

  • 

    Peptides

  • 

    Supplements

  • 

    Sexual Enhancement

  • 

    Apixabn intermediates

  • 

    Bexagliflozin Intermediate

  • 

    Lurasidon intermediates

  • 

    Vortioxeti intermediates

  • 

    Selpercatinib intermediates

  • 

    Indacater intermediates

  • 

    Elacestrant intermediates

  • 

    Repotrectinib/TPX-0005 intermediate

  • 

    Baricitinib Intermediate

  • 

    Ropsacitinib intermediate

  • 

    Other intermediates

WELCOME

+86-13031714605
info@millionpharm.com
+86-13031714605

Products

  • Pharmaceutical API

    • Cerebro-cardiovascular

    • Central nervous system

    • Cancer/tumor

    • Anti-diabetics

    • R&D&Pipeline

    • Other APIS

  • Advanced Intermediates

  • Company

    • About us

    • Partners

    • Value

    • Careers

  • R&D&Site

  • News&Events

  • Sustainability

Contact Us

Jinan Million Pharmaceutical Co., Ltd

(Jinan Milin Pharmaceutical Co., Ltd)

+86-13031714605 (Wechat)
+86-13031714605
+86-531-68659554
info@millionpharm.com
Room1-2208, Gaoxin district, Jinan, Shandong
 3299907431

Attention: All products are only for research

© million | All Rights Reserved

Leave A Message

If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.

SUBMIT


+86-13031714605

WhatsApp

Email

Inquiry
